Company Filing History:
Years Active: 2021
Title: Innovations of Junhui Li in Chondroitin Sulfate Oligosaccharides
Introduction
Junhui Li is a prominent inventor based in Hangzhou, China. He has made significant contributions to the field of biochemistry, particularly in the development of fucosylated chondroitin sulfate oligosaccharides. His innovative work has implications for antithrombotic therapies, showcasing the potential for safer treatment options.
Latest Patents
Junhui Li holds a patent for a "Mixture of fucosylated chondroitin sulfate oligosaccharides and method for rapidly producing the same." This invention discloses a mixture with an average molecular weight between 2700 Da and 3600 Da, where 90% of the total components have a molecular weight between 1800 Da and 5400 Da. The mixture exhibits very low anti-FIIa factor activity and very low anti-FXa factor activity, while demonstrating significant activity in selectively inhibiting intrinsic FXase. This invention has been proven to have significant antithrombotic activity without the associated risks of bleeding and hypotension through animal experiments. The method for producing these oligosaccharides utilizes sea cucumber as raw material and includes several steps such as intercepting and concentrating crude polysaccharide, deacetylation, pyrolysis, and membrane separation, achieving rapid preparation and high yield.
Career Highlights
Junhui Li is affiliated with Zhejiang University, where he continues to advance research in his field. His work not only contributes to academic knowledge but also has practical applications in medicine and pharmacology.
Collaborations
Junhui Li collaborates with notable colleagues, including Shiguo Chen and Lufeng Yan, enhancing the scope and impact of his research through teamwork and shared expertise.
Conclusion
Junhui Li's innovative work in the field of fucosylated chondroitin sulfate oligosaccharides represents a significant advancement in biochemistry and medicine. His contributions have the potential to improve therapeutic options for patients, highlighting the importance of continued research and innovation in this area.